Mohammed H Ahmed, MD
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- 2 flags on the record
- Listed below.
- Plans that list them
- 31
- 7 carriers
- Offices
- 2
On the public record
- California licence: Current
- 1 Medical Board action on record
Offices
2 locations · Center for Cardiovascular Care A Medical Corporation · 11 clinicians in this group
Plans that list them
31 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ahmed’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
31 of 31 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A69198 · Current
Licence status: Current · since 1999 · expires 2027-01-31 · Osmania University, Osmania Medical College. Board flags: Prob/Susp-Prob Includes Actual Susp, Limitations on Practice.
Licensee meets requirements for the practice of medicine in California.
Public record actions
| 2025-02-13 | Board disciplineDiscipline | Seven years? probation with various terms and conditions including a 60 day suspension. suspension begins 03/01/2025, until 04/30/2025. restrictions: prohibited from practicing medicine until successful completion of professional boundaries program and has been so notified by the board or its designee; and prohibited from supervising physician assistants and advanced practice nurses. · 8002021078610 |
Respondent committed acts of sexual misconduct, gross negligence, repeated negligence, dishonesty, and failure to maintain adequate and accurate medical records in the care and treatment of one patient. Effective 02/13/2025, revoked, stayed, placed on seven years' probation until anticipated end date of 02/12/2032. Terms and conditions include, but are not limited to, sixty (60) days actual suspension from the practice of medicine beginning the sixteenth day after the effective date of the decision; completing an education course and an ethics course; completing a professional boundaries program prior to practicing medicine; obtaining a practice monitor; required to have a third party chaperone present while consulting, examining or treating female patients; submitting proof of notification of Decision and Accusation to required parties; prohibited from supervising physician assistants and advanced practice nurses; reimbursing the Board its costs of investigation and enforcement in the amount of $30,000.00; submitting quarterly declarations of compliance with all conditions of probation; complying with the Board's probation unit; prohibited from engaging in the practice of medicine in Respondent's or patient's place of residence, unless the patient resides in a skilled nursing facility or other similar licensed facility; and paying costs associated with probation monitoring.
Surgery centers they own
- Evergreen Surgery Center, LLC dba Evergreen Surgery CenterAmbulatory Surgery Center · San Jose, CA75% owner since 2020 · accredited by AAAHCAccreditation Renewed4 inspections, 4 with deficiencies · last 2025-11-20: Requirements Met
Original Medicare doctor bills
$260,540
Medicare paid this office $260,540 for 295 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 210 | $62,332 | $74 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 43 | $35,402 | $823 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 145 | $24,347 | $162 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 52 | $21,854 | $420 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 50 | $15,680 | $157 |
See all 30 services
| Short return visit (20+ min) | 210 | $62,332 | $74 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 43 | $35,402 | $823 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 145 | $24,347 | $162 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 52 | $21,854 | $420 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 50 | $15,680 | $157 |
| Programming of dual lead pacemaker system | 72 | $10,532 | $66 |
| Complete ultrasound of within the brain blood flow | 33 | $8,801 | $267 |
| Ultrasound of leg arteries or artery grafts | 33 | $8,081 | $231 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 41 | $6,317 | $140 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 13 | $5,092 | $392 |
| Ultrasound of both sides of head and neck blood flow | 34 | $4,919 | $145 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 23 | $4,200 | $183 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 75 | $4,128 | $54 |
| Heart rhythm recording, analysis, interpretation and report of continous external ekg over more than 1 week up to 1 weeks | 15 | $4,016 | $251 |
| Programming of dual lead implantable defibrillator system | 16 | $3,988 | $85 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 68 | $3,700 | $54 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 27 | $3,586 | $20 |
| New patient visit (30+ min) | 39 | $3,476 | $89 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 52 | $2,966 | $57 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 45 | $2,916 | $24 |
| Programming of cardiac rhythm monitor system | 16 | $1,293 | $43 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 13 | $1,236 | $20 |
| Complete ultrasound study of arm and leg arteries | 11 | $1,234 | $112 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $1,190 | $70 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 14 | $1,069 | $30 |
| Injection, regadenoson, 0.1 mg | 38 | $929 | None |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 43 | $888 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 57 | $615 | $11 |
| Iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta | 28 | $284 | $10 |
| Infusion, normal saline solution, 250 cc | 52 | $27 | None |
Procedures Medicare counted
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
295 Original Medicare patients in 2024. Average age 76 · Under 65 10% · 85 and older 21% · Women 58% · Also on Medicaid 66% · Health risk score 2.01. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 63% · Diabetes 60% · Heart failure 40% · Chronic kidney disease 31% · Atrial fibrillation 25% · Dementia 18% · COPD 17% · Depression 15% · Stroke 14% · Cancer 7%.
The office billed $521,024, Medicare allowed $352,238 and paid $260,540; for 2,690 services of 46 kinds; $957 of it was for drugs given in the office and $259,584 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 295 | 2,690 | 76 | 2.01 | $521,024 | $260,540 |
| 2023 | 352 | 3,272 | 75 | 2.09 | $469,388 | $257,368 |
| 2022 | 367 | 3,703 | 75 | 2.16 | $576,479 | $251,869 |
| 2021 | 363 | 6,366 | 76 | 2.02 | $972,761 | $429,343 |
| 2020 | 301 | 5,414 | 75 | 2.22 | $647,003 | $306,109 |
| 2019 | 433 | 5,250 | 75 | 2.15 | $712,122 | $337,273 |
| 2018 | 393 | 5,620 | 75 | 2.07 | $637,828 | $278,056 |
| 2017 | 402 | 4,729 | 75 | 1.87 | $523,635 | $237,634 |
| 2016 | 462 | 4,393 | 75 | 1.66 | $554,407 | $255,932 |
| 2015 | 481 | 4,439 | 75 | 1.68 | $599,004 | $302,393 |
| 2014 | 674 | 6,739 | 74 | 1.44 | $867,208 | $450,676 |
| 2013 | 737 | 5,018 | 74 | 1.48 | $1,019,832 | $534,635 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 25 services
| Short return visit (20+ min) | 222 | $71,857 | $80 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 139 | $27,476 | $193 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 46 | $21,111 | $459 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 21 | $19,650 | $936 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 44 | $13,014 | $148 |
| Ultrasound of leg arteries or artery grafts | 45 | $11,868 | $253 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 51 | $8,416 | $159 |
| Complete ultrasound of within the brain blood flow | 28 | $8,210 | $293 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 112 | $6,940 | $61 |
| Programming of dual lead pacemaker system | 58 | $6,528 | $70 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 13 | $5,743 | $442 |
| New patient visit (30+ min) | 56 | $5,089 | $91 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 74 | $4,625 | $62 |
| Ultrasound of both sides of head and neck blood flow | 29 | $4,601 | $159 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 16 | $3,573 | $223 |
| Programming of dual lead implantable defibrillator system | 15 | $2,895 | $97 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 46 | $2,838 | $62 |
| Programming of cardiac rhythm monitor system | 23 | $2,764 | $51 |
| Injection, regadenoson, 0.1 mg | 15 | $2,412 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 130 | $1,859 | $13 |
| Complete ultrasound study of arm and leg arteries | 12 | $1,480 | $123 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $902 | $75 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 21 | $484 | $23 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 25 | $409 | None |
| Infusion, normal saline solution, 250 cc | 46 | $23 | None |
2022: 24 services
| Short return visit (20+ min) | 227 | $73,383 | $80 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 29 | $28,586 | $986 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 119 | $23,471 | $192 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 40 | $19,524 | $488 |
| Ultrasound of leg arteries or artery grafts | 40 | $10,241 | $244 |
| Programming of dual lead pacemaker system | 65 | $8,962 | $75 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 123 | $7,870 | $62 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 44 | $7,401 | $161 |
| Complete ultrasound of within the brain blood flow | 24 | $6,865 | $286 |
| Programming of cardiac rhythm monitor system | 40 | $6,061 | $52 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 77 | $5,138 | $66 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 31 | $5,054 | $82 |
| New patient visit (30+ min) | 55 | $4,817 | $88 |
| Ultrasound of both sides of head and neck blood flow | 27 | $4,357 | $161 |
| Telephone medical discussion with physician, 11-20 minutes | 37 | $4,027 | $84 |
| Programming of dual lead implantable defibrillator system | 12 | $3,470 | $99 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 15 | $2,991 | $199 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 40 | $2,485 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 100 | $1,278 | $12 |
| Insertion of heart rhythm monitor under skin | 16 | $1,219 | $76 |
| Removal of heart rhythm monitor from under the skin | 16 | $904 | $56 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 29 | $684 | $24 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 35 | $531 | None |
| Infusion, normal saline solution, 250 cc | 40 | $21 | None |
2021: 31 services
| Short return visit (20+ min) | 246 | $88,279 | $82 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 47 | $37,505 | $781 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 70 | $35,529 | $508 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 164 | $33,195 | $196 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 61 | $27,380 | $69 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 61 | $20,607 | $50 |
| Complete ultrasound of within the brain blood flow | 65 | $18,479 | $284 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 64 | $12,080 | $94 |
| Ultrasound of leg arteries or artery grafts | 43 | $11,804 | $275 |
| Ultrasound of both sides of head and neck blood flow | 68 | $11,581 | $170 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 125 | $8,967 | $69 |
| Programming of dual lead pacemaker system | 60 | $8,167 | $74 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 44 | $7,688 | $167 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 41 | $7,520 | $39 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 32 | $7,109 | $222 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 17 | $6,990 | $411 |
| New patient visit (30+ min) | 71 | $6,838 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 99 | $6,597 | $65 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $5,614 | $510 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 70 | $4,358 | $62 |
| Telephone medical discussion with physician, 11-20 minutes | 34 | $3,840 | $89 |
| Programming of cardiac rhythm monitor system | 27 | $3,827 | $56 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 171 | $2,633 | $14 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 30 | $2,137 | $40 |
| Insertion of heart rhythm monitor under skin | 23 | $1,797 | $78 |
| Complete ultrasound study of arm and leg arteries | 12 | $1,528 | $127 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 21 | $1,343 | $36 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 47 | $1,138 | $24 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 57 | $1,097 | None |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 16 | $314 | $20 |
| Infusion, normal saline solution, 250 cc | 70 | $38 | None |
2020: 23 services
| Short return visit (20+ min) | 213 | $69,330 | $63 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 68 | $33,114 | $480 |
| Complete ultrasound of within the brain blood flow | 110 | $30,729 | $270 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 141 | $27,646 | $192 |
| Ultrasound of both sides of head and neck blood flow | 116 | $17,638 | $148 |
| Ultrasound of leg arteries or artery grafts | 66 | $17,069 | $251 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 68 | $12,723 | $92 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 73 | $12,413 | $159 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 12 | $8,415 | $647 |
| Programming of dual lead pacemaker system | 57 | $7,289 | $62 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 91 | $7,156 | $73 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 76 | $4,898 | $64 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 68 | $4,069 | $59 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 19 | $3,687 | $194 |
| Complete ultrasound study of arm and leg arteries | 23 | $2,492 | $108 |
| New patient visit (30+ min) | 25 | $2,102 | $84 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 16 | $1,941 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 123 | $1,924 | $14 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 19 | $1,621 | $48 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 62 | $1,286 | None |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 26 | $501 | $19 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 12 | $275 | $23 |
| Infusion, normal saline solution, 250 cc | 69 | $35 | None |
2019: 27 services
| Short return visit (20+ min) | 247 | $65,349 | $59 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 164 | $30,581 | $177 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 64 | $29,673 | $464 |
| Complete ultrasound of within the brain blood flow | 101 | $26,667 | $259 |
| Ultrasound of both sides of head and neck blood flow | 119 | $18,487 | $154 |
| Ultrasound of leg arteries or artery grafts | 66 | $16,714 | $246 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 22 | $15,392 | $700 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 64 | $12,221 | $95 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 76 | $11,718 | $150 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 133 | $8,834 | $65 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 101 | $7,600 | $72 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $6,398 | $492 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 27 | $6,180 | $221 |
| Programming of dual lead pacemaker system | 60 | $5,495 | $55 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 65 | $3,919 | $58 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $3,752 | $313 |
| New patient visit (30+ min) | 40 | $3,277 | $82 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 182 | $3,052 | $13 |
| Complete ultrasound study of arm and leg arteries | 25 | $2,091 | $84 |
| Insertion of tube into aorta | 16 | $1,702 | $106 |
| Review by radiologist of both arms or legs arteries image | 17 | $1,395 | $82 |
| Review by radiologist of abdominal aorta and both leg arteries image | 17 | $1,299 | $76 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 53 | $1,276 | None |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 12 | $1,181 | $98 |
| Evaluation of implantable heart and blood vessel monitoring system | 12 | $517 | $34 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 22 | $499 | $23 |
| Infusion, normal saline solution, 250 cc | 66 | $32 | None |
2018: 25 services
| Short return visit (20+ min) | 252 | $66,404 | $58 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 63 | $29,882 | $474 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 158 | $29,391 | $178 |
| Ultrasound of both sides of head and neck blood flow | 125 | $20,907 | $162 |
| Complete ultrasound of within the brain blood flow | 103 | $16,021 | $151 |
| Ultrasound of leg arteries or artery grafts | 51 | $13,335 | $247 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 63 | $11,200 | $89 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 134 | $10,533 | $74 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 52 | $8,603 | $154 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 11 | $8,070 | $734 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 38 | $6,901 | $182 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 94 | $5,396 | $57 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $5,109 | $464 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 12 | $4,829 | $402 |
| Programming of dual lead pacemaker system | 52 | $4,303 | $48 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 64 | $3,713 | $57 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 197 | $3,192 | $14 |
| New patient visit (30+ min) | 26 | $2,367 | $91 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 56 | $1,636 | None |
| Complete ultrasound study of arm and leg arteries | 17 | $1,230 | $72 |
| Review by radiologist of abdominal aorta and both leg arteries image | 13 | $932 | $72 |
| Administration of influenza virus vaccine | 12 | $309 | $26 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 15 | $260 | $17 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 11 | $241 | $22 |
| Infusion, normal saline solution, 250 cc | 64 | $30 | None |
2017: 21 services
| Short return visit (20+ min) | 305 | $63,279 | $55 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 140 | $27,831 | $197 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 56 | $25,713 | $459 |
| Ultrasound of both sides of head and neck blood flow | 110 | $17,587 | $160 |
| Complete ultrasound of within the brain blood flow | 57 | $14,838 | $260 |
| Ultrasound of leg arteries or artery grafts | 51 | $12,725 | $240 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 56 | $9,786 | $87 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 54 | $8,568 | $140 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 114 | $7,976 | $68 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 28 | $5,632 | $201 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 67 | $3,503 | $52 |
| Programming of dual lead pacemaker system | 43 | $3,408 | $47 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 57 | $3,398 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 179 | $2,618 | $13 |
| New patient visit (30+ min) | 29 | $2,497 | $86 |
| Insertion of tube into aorta | 12 | $1,304 | $109 |
| Return visit (30+ min) | 18 | $996 | $34 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 45 | $988 | None |
| Review by radiologist of abdominal aorta and both leg arteries image | 13 | $915 | $70 |
| Review by radiologist of both arms or legs arteries image | 11 | $562 | $51 |
| Infusion, normal saline solution, 250 cc | 55 | $22 | None |
2016: 22 services
| Return visit (30+ min) | 322 | $73,428 | $85 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 120 | $25,251 | $205 |
| Ultrasound of both sides of head and neck blood flow | 109 | $18,813 | $169 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 40 | $18,323 | $458 |
| Short return visit (20+ min) | 211 | $18,226 | $64 |
| Complete ultrasound of within the brain blood flow | 57 | $11,257 | $197 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 122 | $9,179 | $74 |
| Ultrasound of leg arteries or artery grafts | 44 | $8,633 | $192 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 40 | $7,399 | $92 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 45 | $7,182 | $150 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $6,326 | $487 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 29 | $5,939 | $205 |
| New patient visit (45+ min) | 41 | $5,025 | $123 |
| Programming of dual lead pacemaker system | 43 | $3,143 | $45 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 182 | $3,030 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 43 | $2,587 | $60 |
| Insertion of tube into aorta | 21 | $2,399 | $114 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 42 | $2,265 | $53 |
| Review by radiologist of abdominal aorta and both leg arteries image | 16 | $1,162 | $73 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 36 | $1,007 | None |
| Complete ultrasound study of arm and leg arteries | 16 | $859 | $54 |
| Infusion, normal saline solution, 250 cc | 46 | $16 | None |
2015: 20 services
| Return visit (30+ min) | 354 | $101,123 | $90 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 136 | $30,373 | $219 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 50 | $24,382 | $488 |
| Ultrasound of both sides of head and neck blood flow | 122 | $22,203 | $181 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 50 | $13,200 | $132 |
| Ultrasound of leg arteries or artery grafts | 56 | $13,056 | $229 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 66 | $11,154 | $164 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 105 | $8,571 | $77 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 29 | $8,211 | $257 |
| Complete ultrasound of within the brain blood flow | 27 | $6,522 | $242 |
| New patient visit (60+ min) | 31 | $5,404 | $174 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 217 | $3,678 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 61 | $3,248 | $52 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 49 | $3,076 | $63 |
| Programming of dual lead pacemaker system | 44 | $3,073 | $50 |
| Short return visit (20+ min) | 44 | $2,934 | $58 |
| Long return visit (40+ min) | 17 | $1,912 | $112 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 39 | $1,171 | None |
| Complete ultrasound study of arm and leg arteries | 22 | $1,142 | $52 |
| Infusion, normal saline solution, 250 cc | 51 | $15 | None |
2014: 31 services
| Return visit (30+ min) | 418 | $92,144 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 193 | $43,987 | $224 |
| Short return visit (20+ min) | 395 | $40,090 | $54 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 76 | $37,787 | $497 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 19 | $35,796 | $1,705 |
| Ultrasound of both sides of head and neck blood flow | 133 | $23,726 | $176 |
| Ultrasound of leg arteries or artery grafts | 91 | $21,244 | $231 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 109 | $18,305 | $158 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 76 | $16,890 | $132 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 147 | $12,113 | $77 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 34 | $8,902 | $262 |
| Complete ultrasound of within the brain blood flow | 26 | $6,145 | $236 |
| Complete ultrasound study of arm and leg arteries | 111 | $6,113 | $55 |
| Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | 63 | $6,002 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 350 | $5,778 | $15 |
| Long return visit (40+ min) | 35 | $4,934 | $133 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 75 | $4,773 | $64 |
| New patient visit (45+ min) | 36 | $4,540 | $126 |
| New patient visit (60+ min) | 25 | $4,488 | $180 |
| Programming of dual lead pacemaker system | 56 | $4,346 | $51 |
| Ultrasound study of veins of both arms or legs including assessment of functional maneuvers | 34 | $3,364 | $99 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 44 | $2,398 | $54 |
| Dxa bone density measurement of hip, pelvis, spine | 37 | $2,315 | $61 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 18 | $2,092 | $110 |
| Insertion of tube into aorta | 11 | $1,511 | $126 |
| Programming of dual lead implantable defibrillator system | 11 | $1,193 | $66 |
| Review by radiologist of both arms or legs arteries image | 11 | $619 | $56 |
| Review by radiologist of abdominal aorta image | 11 | $537 | $49 |
| Administration of influenza virus vaccine | 14 | $436 | $31 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 14 | $211 | $15 |
| Infusion, normal saline solution, 250 cc | 76 | $19 | None |
2013: 32 services
| Short return visit (20+ min) | 530 | $112,344 | $62 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 137 | $69,717 | $505 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 25 | $55,815 | $1,800 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 256 | $46,426 | $178 |
| Ultrasound of both sides of head and neck blood flow | 211 | $40,088 | $183 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 137 | $25,324 | $131 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 109 | $19,758 | $162 |
| Ultrasound of leg arteries or artery grafts | 94 | $17,706 | $184 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 208 | $16,700 | $78 |
| New patient visit (45+ min) | 87 | $12,128 | $139 |
| Injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) | 103 | $11,628 | None |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 44 | $11,165 | $254 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 136 | $8,975 | $66 |
| Complete ultrasound study of arm and leg arteries | 130 | $7,904 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 393 | $7,235 | $16 |
| Complete ultrasound of within the brain blood flow | 29 | $6,024 | $201 |
| Ultrasound study of veins of both arms or legs including assessment of functional maneuvers | 45 | $4,499 | $100 |
| Programming of dual lead pacemaker system | 59 | $4,481 | $50 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 14 | $4,280 | $306 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 25 | $3,429 | $111 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 58 | $3,169 | $53 |
| Dxa bone density measurement of hip, pelvis, spine | 29 | $1,832 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,670 | $62 |
| Return visit (30+ min) | 19 | $1,636 | $82 |
| Programming of dual lead implantable defibrillator system | 12 | $1,618 | $74 |
| Insertion of tube into aorta | 11 | $1,525 | $127 |
| Administration of influenza virus vaccine | 30 | $964 | $32 |
| Review by radiologist of both arms or legs arteries image | 11 | $594 | $54 |
| Review by radiologist of abdominal aorta image | 11 | $514 | $47 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 30 | $429 | $14 |
| Measurement of heart blood flow and respiration | 12 | $262 | $20 |
| Infusion, normal saline solution, 250 cc | 137 | $31 | None |
Medicaid work
$23,919 in 2024
Medicaid paid $23,919 for 1,211 billed services this clinician did in 2024, up to 87 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 307 | $11,614 |
| Return visit (30+ min) | 616 | $9,310 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 92 | $1,753 |
| External mobile cardiovascular telemetry with electrocardiographic recording, concurrent computerized real time data analysis and greater than 24 hours of accessible ECG data storage (retrievable with query) with ECG triggered and patient selected events transmitted to a remote attended surveillance center for up to 30 days; technical support for connection and patient instructions for use, attended surveillance, analysis and transmission of daily and emergent data reports as prescribed by a physician or other qualified health care professional | 14 | $744 |
| Short return visit (20+ min) | 131 | $359 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, including analysis of 1 or more recorded physiologic cardiovascular data elements from all internal and external sensors, analysis, review(s) and report(s) by a physician or other qualified health care professional | 25 | $64 |
| Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; dual lead pacemaker system | 12 | $50 |
| XTRNL MOBILE CV TELEMETRY W/I&REPORT 30 DAYS | 14 | $24 |
| 2024 | 1,211 | 8 | 87 | $23,919 |
| 2023 | 1,744 | 8 | 68 | $24,353 |
| 2022 | 1,364 | 6 | 68 | $25,155 |
| 2021 | 1,860 | 9 | 54 | $39,903 |
| 2020 | 1,817 | 12 | 73 | $57,014 |
| 2019 | 1,849 | 13 | 84 | $49,708 |
| 2018 | 1,233 | 8 | 46 | $26,895 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 346 | $11,133 |
| Return visit (30+ min) | 673 | $10,210 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 213 | $1,085 |
| Short return visit (20+ min) | 397 | $713 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 62 | $612 |
| Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; subcutaneous cardiac rhythm monitor system | 15 | $263 |
| New patient visit (45+ min) | 25 | $261 |
| Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; dual lead pacemaker system | 13 | $76 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 266 | $11,371 |
| Return visit (30+ min) | 549 | $8,999 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 62 | $2,353 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 110 | $1,097 |
| Short return visit (20+ min) | 361 | $964 |
| Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; subcutaneous cardiac rhythm monitor system | 16 | $371 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 287 | $16,037 |
| Return visit (30+ min) | 641 | $11,227 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 116 | $4,045 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 290 | $2,558 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 13 | $1,833 |
| Tc99m sestamibi | 26 | $1,739 |
| Long return visit (40+ min) | 18 | $1,030 |
| Short return visit (20+ min) | 456 | $832 |
| CARDIOVASCULAR STRESS TEST | 13 | $604 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 289 | $20,436 |
| Long return visit (40+ min) | 305 | $11,817 |
| Return visit (30+ min) | 360 | $7,053 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 106 | $5,252 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 32 | $4,175 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 189 | $2,533 |
| CARDIOVASCULAR STRESS TEST | 35 | $1,422 |
| DUPLEX SCAN EXTRACRANIAL ART COMPL BI STUDY | 14 | $1,275 |
| Tc99m sestamibi | 18 | $1,192 |
| TRANSCRANIAL DOPPLER STDY INTRACRANIAL ART COMPL | 12 | $938 |
| Short return visit (20+ min) | 443 | $802 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 14 | $119 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 351 | $21,961 |
| Return visit (30+ min) | 435 | $8,157 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 143 | $6,489 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 308 | $3,619 |
| DUPLEX SCAN EXTRACRANIAL ART COMPL BI STUDY | 71 | $3,384 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 29 | $1,277 |
| Short return visit (20+ min) | 374 | $1,270 |
| TRANSCRANIAL DOPPLER STDY INTRACRANIAL ART COMPL | 12 | $934 |
| CARDIOVASCULAR STRESS TEST | 45 | $802 |
| Tc99m sestamibi | 29 | $785 |
| EXTREMITY STUDY | 12 | $532 |
| New patient visit (45+ min) | 13 | $439 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 197 | $11,243 |
| Return visit (30+ min) | 228 | $6,062 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 91 | $3,453 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 178 | $1,829 |
| DUPLEX SCAN EXTRACRANIAL ART COMPL BI STUDY | 59 | $1,514 |
| TRANSCRANIAL DOPPLER STDY INTRACRANIAL ART COMPL | 43 | $1,511 |
| Short return visit (20+ min) | 423 | $797 |
| CARDIOVASCULAR STRESS TEST | 14 | $487 |
Drugs they prescribed that Part D paid
$337,813
Pharmacies billed $337,813 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,340) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
1,046 generic and 294 brand-name prescriptions · $337,813 in drug cost · 13 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 235 | $261,460 | $1,113 |
| Brilinta | 43 | $37,258 | $866 |
| Ranolazine Er | 210 | $17,459 | $83 |
| Amiodarone | 61 | $2,938 | $48 |
| Metoprolol | 217 | $2,435 | $11 |
See all 19 drugs
| Eliquis | 235 | $261,460 | $1,113 |
| Brilinta | 43 | $37,258 | $866 |
| Ranolazine Er | 210 | $17,459 | $83 |
| Amiodarone | 61 | $2,938 | $48 |
| Metoprolol | 217 | $2,435 | $11 |
| Clopidogrel | 62 | $608 | $10 |
| Isosorbide Mononitrate Er | 52 | $566 | $11 |
| Carvedilol | 48 | $436 | $9 |
| Warfarin | 32 | $386 | $12 |
| Nitroglycerin | 15 | $359 | $24 |
| Losartan | 50 | $344 | $7 |
| Lisinopril | 40 | $327 | $8 |
| Spironolactone | 35 | $274 | $8 |
| Atorvastatin | 31 | $273 | $9 |
| Rosuvastatin | 26 | $220 | $8 |
| Amlodipine Besylate | 45 | $159 | $4 |
| Metoprolol | 26 | $127 | $5 |
| Simvastatin | 13 | $124 | $10 |
| Furosemide | 11 | $20 | $2 |
Year by year
| 2024 | 1,340 | 269 | 0% (0) | 22% | $337,813 |
| 2023 | 1,222 | 240 | 0% (0) | 23% | $350,723 |
| 2022 | 1,147 | 229 | None | 21% | $279,354 |
| 2021 | 998 | 179 | None | 17% | $165,323 |
| 2020 | 907 | 181 | 0% (0) | 15% | $124,982 |
| 2019 | 963 | 192 | None | 22% | $140,937 |
| 2018 | 1,139 | 234 | None | 22% | $160,663 |
| 2017 | 1,175 | 236 | None | 18% | $100,203 |
| 2016 | 950 | 178 | None | 18% | $85,610 |
| 2015 | 1,495 | 225 | None | None | $139,145 |
| 2014 | 2,569 | 297 | 1% (16) | None | $172,725 |
| 2013 | 3,052 | 339 | 2% (50) | None | $138,331 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Eliquis | 217 | $229,773 | $1,059 |
| Brilinta | 47 | $47,496 | $1,011 |
| Ranolazine Er | 151 | $36,458 | $241 |
| Metoprolol | 172 | $4,250 | $25 |
| Amiodarone | 54 | $2,670 | $49 |
| Isosorbide Mononitrate Er | 62 | $1,876 | $30 |
| Clopidogrel | 50 | $1,098 | $22 |
| Carvedilol | 63 | $1,053 | $17 |
| Losartan | 42 | $739 | $18 |
| Atorvastatin | 49 | $724 | $15 |
| Lisinopril | 32 | $548 | $17 |
| Warfarin | 29 | $542 | $19 |
| Spironolactone | 36 | $538 | $15 |
| Amlodipine Besylate | 28 | $371 | $13 |
| Rosuvastatin | 25 | $299 | $12 |
| Metoprolol | 29 | $229 | $8 |
| Simvastatin | 11 | $151 | $14 |
| Hydrochlorothiazide | 12 | $142 | $12 |
| Levofloxacin | 14 | $132 | $9 |
| Furosemide | 19 | $107 | $6 |
2022: 19 drugs
| Eliquis | 149 | $166,164 | $1,115 |
| Brilinta | 57 | $55,758 | $978 |
| Ranolazine Er | 121 | $19,769 | $163 |
| Metoprolol | 151 | $2,783 | $18 |
| Isosorbide Mononitrate Er | 54 | $1,198 | $22 |
| Amiodarone | 46 | $903 | $20 |
| Clopidogrel | 62 | $868 | $14 |
| Carvedilol | 60 | $637 | $11 |
| Warfarin | 41 | $542 | $13 |
| Rosuvastatin | 20 | $530 | $26 |
| Atorvastatin | 40 | $515 | $13 |
| Metoprolol | 42 | $398 | $9 |
| Lisinopril | 45 | $335 | $7 |
| Spironolactone | 23 | $312 | $14 |
| Amlodipine Besylate | 36 | $223 | $6 |
| Losartan | 24 | $166 | $7 |
| Simvastatin | 12 | $98 | $8 |
| Furosemide | 11 | $54 | $5 |
| Levofloxacin | 12 | $52 | $4 |
2021: 18 drugs
| Eliquis | 107 | $101,838 | $952 |
| Brilinta | 38 | $27,255 | $717 |
| Ranolazine Er | 78 | $9,135 | $117 |
| Metoprolol | 157 | $2,537 | $16 |
| Amiodarone | 20 | $2,142 | $107 |
| Isosorbide Mononitrate Er | 55 | $1,157 | $21 |
| Carvedilol | 50 | $691 | $14 |
| Warfarin | 40 | $580 | $15 |
| Atorvastatin | 45 | $531 | $12 |
| Clopidogrel | 39 | $490 | $13 |
| Metoprolol | 40 | $399 | $10 |
| Lisinopril | 50 | $363 | $7 |
| Amlodipine Besylate | 39 | $300 | $8 |
| Losartan | 24 | $176 | $7 |
| Simvastatin | 14 | $102 | $7 |
| Cephalexin | 11 | $88 | $8 |
| Levofloxacin | 12 | $75 | $6 |
| Furosemide | 19 | $67 | $4 |
2020: 22 drugs
| Eliquis | 71 | $60,089 | $846 |
| Ranolazine Er | 62 | $13,250 | $214 |
| Nuedexta | 11 | $12,186 | $1,108 |
| Brilinta | 14 | $11,949 | $853 |
| Metoprolol | 142 | $2,772 | $20 |
| Isosorbide Mononitrate Er | 76 | $1,460 | $19 |
| Amiodarone | 15 | $773 | $52 |
| Atorvastatin | 31 | $577 | $19 |
| Carvedilol | 52 | $504 | $10 |
| Clopidogrel | 33 | $466 | $14 |
| Warfarin | 31 | $402 | $13 |
| Lisinopril | 53 | $326 | $6 |
| Rosuvastatin | 16 | $278 | $17 |
| Losartan | 25 | $252 | $10 |
| Metoprolol | 24 | $235 | $10 |
| Amlodipine Besylate | 31 | $214 | $7 |
| Simvastatin | 15 | $124 | $8 |
| Hydrochlorothiazide | 17 | $81 | $5 |
| Cephalexin | 11 | $77 | $7 |
| Furosemide | 18 | $74 | $4 |
| Levofloxacin | 12 | $61 | $5 |
| Diazepam | 14 | $31 | $2 |
2019: 21 drugs
| Eliquis | 96 | $67,625 | $704 |
| Ranexa | 39 | $17,020 | $436 |
| Ranolazine Er | 49 | $12,217 | $249 |
| Brilinta | 13 | $8,627 | $664 |
| Metoprolol | 132 | $2,797 | $21 |
| Rosuvastatin | 15 | $1,032 | $69 |
| Isosorbide Mononitrate Er | 66 | $1,018 | $15 |
| Carvedilol | 49 | $571 | $12 |
| Clopidogrel | 29 | $534 | $18 |
| Amiodarone | 23 | $457 | $20 |
| Atorvastatin | 26 | $408 | $16 |
| Levetiracetam | 15 | $397 | $26 |
| Lisinopril | 51 | $366 | $7 |
| Warfarin | 15 | $349 | $23 |
| Metoprolol | 32 | $275 | $9 |
| Cilostazol | 12 | $248 | $21 |
| Losartan | 20 | $218 | $11 |
| Amlodipine Besylate | 20 | $198 | $10 |
| Atenolol | 14 | $178 | $13 |
| Furosemide | 20 | $148 | $7 |
| Simvastatin | 12 | $102 | $8 |
2018: 26 drugs
| Ranexa | 80 | $44,127 | $552 |
| Eliquis | 45 | $28,012 | $622 |
| Brilinta | 16 | $10,055 | $628 |
| Novolog Mix 70-30 | 11 | $7,360 | $669 |
| Bystolic | 20 | $5,750 | $287 |
| Metoprolol | 148 | $2,747 | $19 |
| Isosorbide Mononitrate Er | 57 | $978 | $17 |
| Isosorbide Dinitrate | 12 | $836 | $70 |
| Rosuvastatin | 17 | $737 | $43 |
| Carvedilol | 82 | $671 | $8 |
| Clopidogrel | 49 | $546 | $11 |
| Amiodarone | 28 | $488 | $17 |
| Amlodipine Besylate | 49 | $483 | $10 |
| Atorvastatin | 30 | $454 | $15 |
| Warfarin | 17 | $437 | $26 |
| Cilostazol | 13 | $379 | $29 |
| Metformin | 27 | $361 | $13 |
| Metoprolol | 23 | $251 | $11 |
| Lisinopril | 41 | $248 | $6 |
| Losartan | 27 | $228 | $8 |
| Simvastatin | 19 | $212 | $11 |
| Furosemide | 32 | $205 | $6 |
| Atenolol | 15 | $143 | $10 |
| Omeprazole | 11 | $124 | $11 |
| Cephalexin | 13 | $91 | $7 |
| Hydrochlorothiazide | 14 | $54 | $4 |
2017: 25 drugs
| Ranexa | 59 | $35,592 | $603 |
| Brilinta | 27 | $12,218 | $453 |
| Pradaxa | 18 | $9,722 | $540 |
| Eliquis | 16 | $7,532 | $471 |
| Bystolic | 14 | $2,497 | $178 |
| Metoprolol | 76 | $1,947 | $26 |
| Isosorbide Mononitrate Er | 79 | $1,525 | $19 |
| Carvedilol | 144 | $999 | $7 |
| Isosorbide Dinitrate | 12 | $751 | $63 |
| Clopidogrel | 52 | $630 | $12 |
| Amiodarone | 27 | $616 | $23 |
| Atorvastatin | 28 | $536 | $19 |
| Amlodipine Besylate | 55 | $401 | $7 |
| Metformin | 37 | $366 | $10 |
| Lisinopril | 58 | $341 | $6 |
| Warfarin | 25 | $337 | $13 |
| Metoprolol | 35 | $306 | $9 |
| Simvastatin | 36 | $293 | $8 |
| Estradiol | 14 | $286 | $20 |
| Losartan | 26 | $211 | $8 |
| Alendronate | 15 | $173 | $12 |
| Atenolol | 15 | $152 | $10 |
| Omeprazole | 14 | $102 | $7 |
| Furosemide | 18 | $92 | $5 |
| Gabapentin | 13 | $89 | $7 |
2016: 19 drugs
| Ranexa | 53 | $34,313 | $647 |
| Brilinta | 11 | $6,296 | $572 |
| Pradaxa | 13 | $5,762 | $443 |
| Bystolic | 14 | $2,507 | $179 |
| Isosorbide Mononitrate Er | 73 | $2,057 | $28 |
| Metoprolol | 49 | $1,589 | $32 |
| Carvedilol | 140 | $1,311 | $9 |
| Clopidogrel | 65 | $1,300 | $20 |
| Atorvastatin | 30 | $746 | $25 |
| Amlodipine Besylate | 57 | $497 | $9 |
| Simvastatin | 23 | $406 | $18 |
| Allopurinol | 11 | $331 | $30 |
| Metoprolol | 27 | $305 | $11 |
| Losartan | 19 | $298 | $16 |
| Atenolol | 31 | $258 | $8 |
| Amiodarone | 18 | $250 | $14 |
| Alendronate | 15 | $130 | $9 |
| Lisinopril | 17 | $117 | $7 |
| Furosemide | 16 | $93 | $6 |
2015: 32 drugs
| Ranexa | 103 | $46,502 | $451 |
| Coreg Cr | 16 | $8,590 | $537 |
| Eliquis | 17 | $6,072 | $357 |
| Pradaxa | 14 | $5,584 | $399 |
| Crestor | 14 | $5,230 | $374 |
| Advair Diskus | 12 | $3,688 | $307 |
| Isosorbide Mononitrate Er | 134 | $2,956 | $22 |
| Metoprolol | 91 | $2,855 | $31 |
| Benicar | 11 | $2,641 | $240 |
| Bystolic | 23 | $2,410 | $105 |
| Edarbyclor | 12 | $2,319 | $193 |
| Carvedilol | 196 | $1,649 | $8 |
| Clopidogrel | 91 | $1,559 | $17 |
| Cilostazol | 30 | $1,250 | $42 |
| Proair Hfa | 19 | $1,162 | $61 |
| Atorvastatin | 39 | $1,159 | $30 |
| Amlodipine Besylate | 68 | $741 | $11 |
| Metoprolol | 40 | $396 | $10 |
| Simvastatin | 38 | $351 | $9 |
| Omeprazole | 25 | $324 | $13 |
| Amiodarone | 18 | $281 | $16 |
| Losartan | 17 | $250 | $15 |
| Furosemide | 37 | $217 | $6 |
| Losartan-Hydrochlorothiazide | 24 | $176 | $7 |
| Lisinopril | 21 | $163 | $8 |
| Alendronate | 15 | $162 | $11 |
| Warfarin | 21 | $149 | $7 |
| Allopurinol | 11 | $148 | $13 |
| Metformin | 11 | $144 | $13 |
| Hydrochlorothiazide | 23 | $141 | $6 |
| Gabapentin | 11 | $119 | $11 |
| Cephalexin | 14 | $92 | $7 |
2014: 46 drugs
| Ranexa | 118 | $35,604 | $302 |
| Crestor | 41 | $14,739 | $359 |
| Coreg Cr | 39 | $11,307 | $290 |
| Pradaxa | 27 | $9,619 | $356 |
| Advair Diskus | 22 | $6,509 | $296 |
| Amitiza | 16 | $5,743 | $359 |
| Isosorbide Mononitrate Er | 253 | $5,028 | $20 |
| Benicar Hct | 19 | $4,423 | $233 |
| Eliquis | 13 | $4,369 | $336 |
| Benicar | 18 | $3,884 | $216 |
| Metoprolol | 101 | $3,622 | $36 |
| Carvedilol | 343 | $3,397 | $10 |
| Clopidogrel | 146 | $3,102 | $21 |
| Bystolic | 16 | $2,348 | $147 |
| Atorvastatin | 55 | $2,301 | $42 |
| Cilostazol | 46 | $1,485 | $32 |
| Pravastatin | 17 | $801 | $47 |
| Simvastatin | 60 | $733 | $12 |
| Potassium Chloride | 16 | $724 | $45 |
| Amlodipine Besylate | 96 | $719 | $7 |
| Levothyroxine | 40 | $640 | $16 |
| Gabapentin | 39 | $627 | $16 |
| Carbidopa-Levodopa | 13 | $617 | $47 |
| Amiodarone | 54 | $617 | $11 |
| Metoprolol | 40 | $558 | $14 |
| Montelukast | 14 | $544 | $39 |
| Warfarin | 61 | $514 | $8 |
| Pramipexole Dihydrochloride | 11 | $483 | $44 |
| Omeprazole | 35 | $480 | $14 |
| Metformin | 43 | $463 | $11 |
| Levetiracetam | 11 | $459 | $42 |
| Losartan | 33 | $447 | $14 |
| Lisinopril | 55 | $436 | $8 |
| Furosemide | 68 | $327 | $5 |
| Hydrochlorothiazide | 36 | $243 | $7 |
| Brimonidine | 12 | $207 | $17 |
| Ramipril | 11 | $191 | $17 |
| Allopurinol | 14 | $151 | $11 |
| Losartan-Hydrochlorothiazide | 13 | $150 | $12 |
| Clonidine | 18 | $148 | $8 |
| Cephalexin | 17 | $138 | $8 |
| Alendronate | 12 | $134 | $11 |
| Atenolol | 26 | $134 | $5 |
| Sertraline | 11 | $101 | $9 |
| Lovastatin | 12 | $101 | $8 |
| Famotidine | 11 | $45 | $4 |
2013: 49 drugs
| Clopidogrel | 212 | $15,623 | $74 |
| Ranexa | 67 | $15,335 | $229 |
| Crestor | 54 | $12,419 | $230 |
| Coreg Cr | 60 | $11,360 | $189 |
| Isosorbide Mononitrate Er | 397 | $6,162 | $16 |
| Pradaxa | 15 | $4,364 | $291 |
| Advair Diskus | 16 | $4,302 | $269 |
| Carvedilol | 401 | $4,301 | $11 |
| Benicar Hct | 31 | $4,193 | $135 |
| Nexium | 12 | $2,610 | $218 |
| Atorvastatin | 81 | $2,593 | $32 |
| Metoprolol | 75 | $2,335 | $31 |
| Benicar | 16 | $2,322 | $145 |
| Bystolic | 18 | $1,716 | $95 |
| Micardis Hct | 12 | $1,661 | $138 |
| Cilostazol | 32 | $1,611 | $50 |
| Potassium Chloride | 28 | $1,254 | $45 |
| Simvastatin | 101 | $984 | $10 |
| Gabapentin | 40 | $976 | $24 |
| Amiodarone | 84 | $858 | $10 |
| Amlodipine Besylate | 116 | $847 | $7 |
| Lisinopril | 111 | $839 | $8 |
| Metoprolol | 64 | $695 | $11 |
| Losartan | 36 | $626 | $17 |
| Welchol | 11 | $547 | $50 |
| Omeprazole | 25 | $538 | $22 |
| Pravastatin | 14 | $471 | $34 |
| Calcitriol | 13 | $451 | $35 |
| Furosemide | 77 | $419 | $5 |
| Levothyroxine | 27 | $407 | $15 |
| Donepezil | 23 | $356 | $15 |
| Metformin | 36 | $346 | $10 |
| Hydrochlorothiazide | 47 | $339 | $7 |
| Warfarin | 29 | $332 | $11 |
| Tamsulosin | 17 | $331 | $19 |
| Sertraline | 12 | $316 | $26 |
| Pantoprazole | 19 | $308 | $16 |
| Nitrostat | 14 | $286 | $20 |
| Alendronate | 16 | $269 | $17 |
| Cephalexin | 27 | $250 | $9 |
| Famotidine | 29 | $223 | $8 |
| Atenolol | 22 | $154 | $7 |
| Clonidine | 18 | $144 | $8 |
| Losartan-Hydrochlorothiazide | 14 | $143 | $10 |
| Lovastatin | 12 | $109 | $9 |
| Diazepam | 31 | $69 | $2 |
| Naproxen | 11 | $68 | $6 |
| Amitriptyline | 13 | $58 | $4 |
| Alprazolam | 14 | $57 | $4 |
Money from drug and device companies
$483 in 2025
| 2025 | 5 | 29 | None | $483 |
| 2024 | 7 | 74 | None | $1,158 |
| 2023 | 11 | 55 | None | $942 |
| 2022 | 8 | 76 | None | $1,252 |
| 2021 | 13 | 72 | None | $1,395 |
| 2020 | 13 | 45 | None | $983 |
| 2019 | 12 | 60 | None | $1,179 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Gallant | $367 | 24 payments
|
| Pfizer | Eliquis | $39 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $32 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $25 | 1 payment
|
| Biotronik | Amvia Edge | $21 | 1 payment
|
See all 29 published payments
| Pfizer | Meals · 2025-11-24 | Eliquis | $25 |
| Biotronik | Meals · 2025-10-09 | Amvia Edge | $21 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-29 | Camzyos | $25 |
| Abbott Laboratories | Meals · 2025-09-24 | Gallant | $22 |
| Abbott Laboratories | Meals · 2025-09-24 | Gallant | $10 |
| Abbott Laboratories | Meals · 2025-09-24 | Gallant | $7 |
| Abbott Laboratories | Meals · 2025-09-18 | Assurity | $22 |
| Abbott Laboratories | Meals · 2025-09-18 | Assurity | $19 |
| Abbott Laboratories | Meals · 2025-07-25 | Gallant | $15 |
| Abbott Laboratories | Meals · 2025-07-23 | Gallant | $10 |
| Abbott Laboratories | Meals · 2025-07-14 | Assurity | $23 |
| Abbott Laboratories | Meals · 2025-06-24 | Merlin@Home | $21 |
| Abbott Laboratories | Meals · 2025-05-22 | Gallant | $10 |
| Pfizer | Meals · 2025-05-20 | Eliquis | $14 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-05 | Jardiance | $32 |
| Abbott Laboratories | Meals · 2025-04-30 | Gallant | $15 |
| Abbott Laboratories | Meals · 2025-04-04 | Gallant | $4 |
| Abbott Laboratories | Meals · 2025-02-21 | Assurity | $10 |
| Abbott Laboratories | Meals · 2025-02-21 | Assurity | $14 |
| Abbott Laboratories | Meals · 2025-02-21 | Gallant | $29 |
| Abbott Laboratories | Meals · 2025-02-21 | Gallant | $26 |
| Abbott Laboratories | Meals · 2025-02-21 | Gallant | $24 |
| Abbott Laboratories | Meals · 2025-02-21 | Gallant | $10 |
| Abbott Laboratories | Meals · 2025-02-21 | Jot Dx | $10 |
| Abbott Laboratories | Meals · 2025-02-21 | Jot Dx | $10 |
| Abbott Laboratories | Meals · 2025-02-19 | Gallant | $18 |
| Abbott Laboratories | Meals · 2025-01-13 | Assurity | $3 |
| Abbott Laboratories | Meals · 2025-01-13 | Assurity | $22 |
| Abbott Laboratories | Meals · 2025-01-13 | Assurity | $8 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,158
| Abbott Laboratories | Gallant | $929 | 63 payments
|
| Biotronik | Biomonitor | $100 | 5 payments
|
| Medtronic | Azure Xt Dr Mri Surescan | $35 | 2 payments
|
| LivaNova USA | Vns Therapy Symmetry Model 8103 Generator | $31 | 1 payment
|
| Genzyme | Fabrazyme | $27 | 1 payment
|
| Pfizer | Eliquis | $21 | 1 payment
|
| Boston Scientific | Watchman Flx | $15 | 1 payment
|
2023: $942
| Abbott Laboratories | Assurity | $567 | 40 payments
|
| Pfizer | Eliquis | $69 | 3 payments
|
| Genzyme | Fabrazyme | $64 | 3 payments
|
| B. Braun Medical | Dialog+ | $64 | 1 payment
|
| Novo Nordisk | Rybelsus | $34 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $29 | 1 payment
|
| Nestle Healthcare Nutrition | Zenpep | $27 | 1 payment
|
| Lundbeck | Vyepti | $27 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $24 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $21 | 1 payment
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $16 | 1 payment
|
2022: $1,252
| Abbott Laboratories | Confirm Rx | $706 | 50 payments
|
| Biotronik | Acticor 7 Vr-T Dx | $343 | 15 payments
|
| Pfizer | Eliquis | $71 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $61 | 3 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $18 | 1 payment
|
| Kyowa Kirin | Nourianz | $18 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | None | $18 | 1 payment
|
| Impulse Dynamics (USA) | Optimizer | $17 | 1 payment
|
2021: $1,395
| Abbott Laboratories | Confirm Rx | $543 | 29 payments
|
| Janssen Pharmaceuticals | Ponvory | $256 | 9 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $150 | 7 payments
|
| Biotronik | Edora | $144 | 8 payments
|
| Kyowa Kirin | Nourianz | $106 | 5 payments
|
| Teva Pharmaceuticals USA | Ajovy | $47 | 2 payments
|
| Medtronic | Endurant | $47 | 1 payment
|
| AbbVie | Ubrelvy | $21 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $21 | 1 payment
|
| Philips Electronics North America | (6585) Omniwire | $21 | 1 payment
|
| Pfizer | Eliquis | $15 | 1 payment
|
| Novo Nordisk | Rybelsus | $13 | 1 payment
|
| Supernus Pharmaceuticals | Oxtellar Xr | $11 | 1 payment
|
2020: $983
| Abbott Laboratories | Infinity Dbs Pulse Generators | $162 | 3 payments
|
| Supernus Pharmaceuticals | Oxtellar Xr | $158 | 13 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $152 | 8 payments
|
| Amarin Pharma | Vascepa | $86 | 4 payments
|
| Kyowa Kirin | Nourianz | $69 | 3 payments
|
| Amgen | Repatha | $66 | 2 payments
|
| LivaNova USA | Vns Therapy | $62 | 3 payments
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $60 | 1 payment
|
| Biotronik | None | $55 | 1 payment
|
| Avanir Pharmaceuticals | Nuedexta | $37 | 2 payments
|
| Teva Pharmaceuticals USA | Ajovy | $35 | 2 payments
|
| Pfizer | Vyndaqel | $26 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $15 | 1 payment
|
2019: $1,179
| Akcea Therapeutics | Tegsedi | $331 | 6 payments
|
| Biotronik | None | $247 | 7 payments
|
| Boehringer Ingelheim Pharmaceuticals | Pradaxa | $244 | 31 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $71 | 3 payments
|
| Pfizer | Vyndaqel | $63 | 3 payments
|
| Supernus Pharmaceuticals | Oxtellar Xr | $56 | 3 payments
|
| Avanir Pharmaceuticals | Nuedexta | $45 | 2 payments
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $40 | 1 payment
|
| Amgen | Prolia | $23 | 1 payment
|
| iRhythm Technologies | Zio Patch | $21 | 1 payment
|
| Hikma Pharmaceuticals USA | Mitigare | $20 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $18 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 0.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1770593105
- Licence
- CA A69198California A69198: Current · expires 2027-01-31
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Federal specialty code 207RI0011X (207RI0011X)
- Mailing address
- 200 Jose Figueres Ave, Suite 325, San Jose, CA, 95116
- NPI first listed
- 2006-08-08
- NPI last updated
- 2026-06-26
- NPI record certified
- 2026-06-26
This is when the NPI record was last certified, not a medical board exam.